CYP3A4 and breast cancer: A study on tamoxifen-resistant breast cancer [327] revealed that CYP3A4 expression and its epoxide product, 11,12-EET, are upregulated in tamoxifen-resistant MCF-7 cells (TAMR-MCF-7) compared to control MCF-7 cells.